Replies to post #631280 on NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

Thanks so much Chiugray. Yes, I believe they are and will be well protected to have freedom to operate and pursue this entirely new area of immunotherapy. Shorts attacking dendritic cell vaccines all day and night for years, despite being painful, likely kept away a lot of potential competitors and funders, which gives the company a HUGE head start versus other potential companies wanting to enter the field. With such a green field opportunity, and such amazing results continuing to far exceed expectations of those who have had their expectations continually lowered by misinformation, I can't imagine that there will not be a lot of interest in doing combination trials and potential deals with NWBO to pursue combinations. We'll have to see, but that's my view.